QI
AXDX

QS Investors’s Accelerate Diagnostics AXDX Stock Holding History

QS Investors’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2
Closed -$1K – 1899
2018
Q3 		$1K Hold
2
– – ﹤0.01% 1703
2018
Q2 		$1K Hold
2
– – ﹤0.01% 1722
2018
Q1 		$1K Hold
2
– – ﹤0.01% 1726
2017
Q4 		$1K Hold
2
– – ﹤0.01% 1735
2017
Q3 		$1K Hold
2
– – ﹤0.01% 1702
2017
Q2 		$1K Hold
2
– – ﹤0.01% 1710
2017
Q1 		$1K Hold
2
– – ﹤0.01% 1730
2016
Q4 		$1K Hold
2
– – ﹤0.01% 1537
2016
Q3 		$1K Hold
2
– – ﹤0.01% 1523
2016
Q2 		$1K Buy
+2
New +$268 ﹤0.01% 1546
2016
Q1 		– Sell
-1
Closed -$1K – 1985
2015
Q4 		$1K Buy
+1
New +$183 ﹤0.01% 1556

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

QS Investors's AXDX Position: Q4 2018 in Review

QS Investors sold out of Accelerate Diagnostics (AXDX) in Q4 2018, closing a stake of 2 shares — an estimated $1K sold.

QS Investors first reported a position in AXDX in Q4 2015 and held it in 11 quarters. The position peaked at $1K in Q3 2018. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2018.

  • QS Investors reported no remaining Accelerate Diagnostics position as of Q4 2018 after selling out during the quarter.
  • QS Investors sold 2 Accelerate Diagnostics shares in Q4 2018, an estimated $1K.
  • QS Investors first reported a position in Accelerate Diagnostics in Q4 2015 and held it in 11 quarters.
  • QS Investors's Accelerate Diagnostics position peaked at $1K in Q3 2018.
  • 107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2018.

Based on QS Investors's 13F filing for Q4 2018, filed 14 Feb 2019.